| 000 | 01248 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250513214142.0 | ||
| 264 | 0 | _c20000822 | |
| 008 | 200008s 0 0 eng d | ||
| 022 | _a0190-9622 | ||
| 024 | 7 |
_a10.1067/mjd.2000.108319 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLebwohl, M | |
| 245 | 0 | 0 |
_aStrategies to optimize efficacy, duration of remission, and safety in the treatment of plaque psoriasis by using tazarotene in combination with a corticosteroid. _h[electronic resource] |
| 260 |
_bJournal of the American Academy of Dermatology _cAug 2000 |
||
| 300 |
_aS43-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKeratolytic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aNicotinic Acids _xadministration & dosage |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tJournal of the American Academy of Dermatology _gvol. 43 _gno. 2 Pt 3 _gp. S43-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1067/mjd.2000.108319 _zAvailable from publisher's website |
| 999 |
_c10849200 _d10849200 |
||